1
TÍTULO: Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
AUTORES: Murthy, RK; Loi, S; Okines, A; Paplomata, E; Hamilton, E; Hurvitz, SA; Lin, NU; Borges, V; Abramson, V; Anders, C; Bedard, PL; Oliveira, M; Jakobsen, E; Bachelot, T; Shachar, SS; Mueller, V; Braga, S; Duhoux, FP; Greil, R; Cameron, D; Carey, LA; Curigliano, G; Gelmon, K; Hortobagyi, G; Krop, I; Loibl, S; Pegram, M; Slamon, D; Palanca Wessels, MC; Walker, L; Feng, W; Winer, EP; ...Mais
PUBLICAÇÃO: 2020, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 382, NÚMERO: 7
INDEXADO EM: WOS